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Interview with Professor Luke P. Lee
BY MATTHEW COLBERT, CASSIDY HARDIN, MICHELLE 
LEE, ROSA LEE, MELANIE RUSSO, AND NIKHIL CHARI
Dr. Luke P. Lee is a Professor of Bioengineering, Electrical Engineering 
and Computer Science at UC Berkeley. He is a pioneer of technologies 
such as  rapid microfluidic PCR and optofluidic spectroscopy. Dr. Lee is 
also a strong believer in tackling problems with broad-scale social impli-
cations. In 2016, he founded the Biomedical Institute for Global Health 
Research and Technology (BIGHEART) at the National University of 
Singapore. We spoke with Dr. Lee about his mission at BIGHEART, his 
work in establishing microfluidic platforms for rapid polymerase chain 
reaction (PCR) and waterborne pathogen detection, and the importance 
of bringing socially responsible technologies to market.
bioengineering   technology   with 
a   social   responsibility
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BSJ: We’d like to start off by talking about BIGHEART. Can you briefly explain the purpose of BIGHEART and how 
BIGHEART uses multidisciplinary approaches to address modern 
humanitarian and medical challenges?
LL: I originally started my career here in Berkeley, but back then, I didn’t have much funding, physical space, or man-
power to set up this institution. I wanted to create an environment 
where people from different disciplines could work together to solve 
one problem—global health. Of course, there are so many different 
issues within global health that need attention, but I wanted to focus 
on early infectious disease diagnostics and precision medicine using 
organoid chips—tissue cultures that can replicate the behavior and 
complexity of a real organ. Everyone’s metabolic activity is different, 
but even if we assume there is a universal recipe for treating a pa-
tient for a certain disease, certain people may still not be able to han-
dle that treatment. In the case of cancer in Third World countries, 
if the patients are malnourished, they might not be able to handle 
the same toxic compounds that are found in cancer medications. We 
were thinking about how to find the best personalized medicine for 
organoid-on-a-chip technologies. But molecular diagnostics was our 
first priority. That’s why I spent a lot of time developing more effi-
cient technologies to detect DNA and protein biomarkers. That’s one 
of the reasons we’re working on PCR-on-a-chip. If possible, we want 
to detect the pathogen directly without any labeling.
BIGHEART’s goal is to bring scientists together—whether 
they’re engineers, biologists, physicists, even clinicians—to commu-
nicate and solve one project, such as malaria, as a group. But all those 
scientists are busy with their own work, so it’s not always easy for 
them to work on a specific medical issue. We wanted to bring these 
people into one place and allow them to work together without any 
physical or mental barriers.
 BSJ: You spoke briefly about your work in PCR-on-a-chip technology. PCR is a technique that is commonly used in 
biology to amplify a certain section of DNA. What are the current 
applications of PCR?
LL: There are many, many applications. One is rapid and accu-rate measurement of different diseases. In our microfluidic 
PCR device, each circle is a reaction chamber. You can do simulta-
neous tests of different biomarkers for different cancers or infectious 
diseases in each one. The PCR solution is automatically pumped into 
the chambers using a vacuum, and each chamber has an individual 
PCR reaction.
BSJ: Could you briefly highlight the issues and potential ineffi-ciencies with current PCR systems?
LL: Current PCR takes hours. You have to use a heater to change the temperature of the reaction several times to denature the 
DNA and then allow the polymerase to bind (Fig. 1). Many compa-
nies build heater blocks, so you are heating up for denaturing and 
cooling down for annealing, and then you go back up a little bit for 
extension. You have to make a cycle, which takes a lot of power and 
time. We created a technique called ultra-fast photonic PCR using 
LEDs and so-called “plasmonic concept antenna” to heat up and 
cool down the reaction really fast. Instead of one hour for 30 cycles, 
you can do it in two to three minutes. The idea is to use a specific 
wavelength to resonate this plasmonic structure, like gold. The other 
issue with microfluidic PCR is when you heat up the PCR fluid, you 
generate bubbles. We are trying to remove these bubbles by pumping 
them out of the system.
This is not only important for infectious disease detection or 
cancer diagnostics. Everyone in the life sciences needs to use PCR 
to quantify gene information; it’s the only way to amplify DNA. That 
is why PCR is so important and there are so many people compet-
ing with each other to claim that they made ultra-fast and accurate 
PCRs. Some labs might not mind waiting one hour, but if you want 
to screen a lot of samples or build a library and you have to wait one 
Figure 1: Steps of PCR 
cycle.5 Denaturation of 
double stranded DNA 
at high temperature, 
followed by annealing 
of polymerase at lower 
temperature, and elon-
gation of new DNA 
strands.
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hour for one experiment, it can take a lot of time. With microfluidic 
PCR, we can go from one experiment per hour to 100,000 experi-
ments in five minutes, because we also have many wells or chambers 
in each PCR chip (Fig. 2). 15 years of work can be finished in 15 days. 
You can speed up an enormous amount of life science automations 
and capture more reliable biomarker discovery and detection.
A lot of people don’t think we need fast PCR, but it’s not so much 
about speed as it is about collecting massive amounts of data. If you 
really want to make a precision personalized medicine, you need 
to collect all the information about how cellular behaviors change 
with various types of cancers or diseases. We need to build reliable, 
high-density information about these biomarkers. Not only for dis-
ease, but also for our food and our environment. We can prevent 
disease by correlating it with the food we eat. For example, say I got 
cancer and the doctor hypothesized it was because I was eating a 
lot of junk food. If we are able to build these biomarker databases, 
we could trace my eating habits and my DNA information to the 
source and verify the doctor’s hypothesis. In other places, water is 
very important. The DNA of the pathogens that introduce infectious 
diseases is hidden somewhere—in the water, the environment, the 
food—we need to find it.
BSJ: Going back to microfluidic PCR, we wanted to ask: how does the generation of bubbles hamper the efficacy of mi-
crofluidic PCR?1
LL: If there is air trapped in the reaction chamber, when you introduce the PCR solution into the chamber, bubbles will 
dominate the space and you will not have any reactions. This is be-
cause when you heat the chamber, the bubble will expand and push 
all of the DNA and PCR solution out of the chamber. You need to 
pump out the bubble before you begin. We built this ring (Fig. 3) to 
be intentionally gas-permeable so we can remove the bubble before 
the reaction begins, and we developed a degassing method that uses 
a vacuum battery to pump out all of the residual gas trapped inside 
the chamber.
BSJ: To aid in the prevention of bubbles forming in the PCR microfluidic machine, you used a layer of polyethylene 
(PE) and two layers of polydimethylsiloxane (PDMS) (Fig. 3). Can 
you explain how these two substances prevent the formation of bub-
bles?
LL: The gas permittivity of PE is much lower compared to PDMS. We made the top surface of the reaction chamber PE 
to ensure that all the gas would be pumped out laterally through the 
PDMS around the sides of the chamber.
 
BSJ: Could you briefly describe the concept of degas-driven flow?1 
 
LL: The PDMS is very flexible and contains lots of nanopores. After we fabricate a PCR chip, we pump out all of the gas 
inside by putting it in a desiccator. You can remove even the small 
amounts of gas trapped in the nanopores. You cannot see them with 
the naked eye because they are so small—less than a nanometer. If 
you pump out all of the gas from the PDMS, you can build a negative 
pressure environment, lower than the atmosphere. Then you pack-
age it. When you are ready to use it, you can open the package just 
like a potato chip bag —of course, you cannot store in in this negative 
pressure for a long time.  Just like potato chips—if you eat the pota-
to chips after a certain amount of time they’re not crispy anymore, 
right?
Anyway, you pump it down, and then you package it. When you 
are ready, you drop in the PCR solution, and the negative pressure 
draws the solution into the chip. Building that negative pressure in 
the first place is what we call degassing. But our design also adds a 
vacuum battery. If we rely only on the properties of the material to 
degas, the operator of the chip only has about two minutes to drop 
in the PCR solution before the pressure returns to atmospheric. But 
with the vacuum battery, we increased the volume of space you can 
pump air out of, so it’s much more than just the small nanopores 
in the PDMS. Now, we can wait for 15 minutes instead of two. This 
accounts for less efficient human operation of the chip, and the oper-
ator can take more time to drop in the solution.
BSJ: Could you describe what the function of the circumferen-tial degas pump surrounding each chamber is?1
LL: The circumferential degas pump helps to pump out any gas within this chamber. As I mentioned, PDMS can pump out 
gas because there are small, invisible pores which you have already 
vacuumed. It works, but it takes time. Here, we intentionally made 
a space, the circumferential degas pump, where you can have more 
vacuum volume (Fig. 3). This makes it faster to pump out residual 
gas. Also, it’s easier to pump laterally. If you have this kind of design, 
“With microfluidic PCR, we can go 
from one experiment per hour to 
100,000 experiments in five minutes.”
Fig. 4. Vacuum battery on the chip. (A) Image of the two on-chip batteries. Channels are filled with dye for visualization only. (B) The basic unit of the vacuum battery
system pumps fluid by slowly releasing stored vacuum potential via air diffusion over the vacuum lung structures. Black arrows depict trapped air diffusing across the
vacuum lungs, which, in turn, suck fluid in. (C) Equipment-free loading and automatic sample compartmentalization in 10 min (dye). Digital amplification can be
performed as soon as compartmentalization is finished. (D) Flow tuning by varying the main battery volume (auxiliary battery constant). Dashed lines indicate
simulation results, solid lines indicate fitted result, and solid dots indicate experimental averages [mean ± SD; adjusted R2 = 0.99; P < 0.01, analysis of variance (ANOVA);
n = 3]. (E) After opening the s al, the effect f the ti e gap before loa ing samples on the time it takes for the liquid to reach the end of the device was tested. Right
photo shows end-loaded chip. (F) This chip has a long window of operation. It pumps for at least 2.5 hours after opening the vacuum pack (40-min gap time + 110-min
loading time) and has higher reliability compared to conventional degas methods [Pearson’s R = 0.60 (black line) and 0.95 (red line); n = 3].
S C I ENCE ADVANCES | R E S EARCH ART I C L E
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Figure 2: PCR reaction chambers in one of Dr. Lee’s microfluidic PCR 
chips.3 The chambers are filling up over time.
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all the gas bubbles are pumped to the outside.
BSJ: Earlier, you talked briefly about methods of detection for waterborne pathogens. Could you elaborate on what some 
of the limitations of the current methods of waterborne pathogen 
detection are?
LL: All pathogen detection nowadays is culture-based. It takes time. For example, let’s say your kid has an infection. You 
don’t know whether it’s from the water or if it’s an airborne patho-
gen. It happened to my daughter. She had an infection, but we didn’t 
know what happened, so we just drove down to the best children’s 
hospital—at the time, I thought that Stanford’s Children’s Hospital 
was better. Doctors just kept injecting her with different antibiotics 
without knowing what the real problem was. It was really disastrous; 
she was hospitalized for many months. Thankfully, she survived, but 
some people can die. If you just keep on adding antibiotics without 
knowing what the infection is, it’s actually damaging the patient. It’s 
better to treat it with the proper drug that will kill that particular 
pathogen. I had food poisoning the last four days, I couldn’t even eat. 
I don’t know what caused it, but it would’ve been nice. It is critical for 
certain diseases to detect pathogens precisely. 
How can we identify pathogens right now? Either ELISA, which 
is protein-based detection, or PCR, which is DNA-based. We are try-
ing to quickly detect the specific fingerprint of the pathogen from its 
outer surface. It’s challenging, but we’re trying to do our best.   
BSJ: Could you briefly describe what plasmonic bacteria are? How did you modify water-borne pathogens to create 
plasmonic bacteria?2    
LL: This kind of solution we use is nothing but gold nano-plas-monic particles. Actually, it’s not very expensive; it’s a salt 
solution—it costs less than a few cents! We wanted to be able to de-
tect pathogens without lysing them, which you have to do to detect 
the DNA inside. Our idea was to detect a chemical signature on the 
surface of the pathogen. Just like how your faces all exhibit differ-
ent phenotypes, the surfaces of pathogens exhibit unique chem-
ical structures. Unfortunately, the surfaces of all pathogens look 
quite similar. There are a few vibrational spectra that are different, 
but they’re difficult to differentiate because the signal is very weak. 
Wrapping the bacteria in gold nanoparticles helps to amplify the 
chemical signal (Fig. 5). 
All chemicals have a vibrational spectrum, and we’re using vi-
brational spectroscopy called surface-enhanced Raman scattering 
(SERS) to detect these different spectra. Since these vibrations are 
normally so weak, we have to use the plasmonic bacteria to amplify 
the vibrational scattering signal. We also measure the signal from the 
consumption of reagents and biological samples (lower cost/test),
higher single-mol cule de ction eﬃc ency in a reduced reaction vo-
lume, shortened nalysis time through faster cycling, and portabili y
and automation for use by minimally trained personnel (Hung et al.,
2017; Sayad et al., 2018). Thus, substantial eﬀorts have been made to
improve the speed and performance of microﬂuidic PCR methods that
have been used in many diagnostic and research ﬁelds, such as virus
detection, disease-associated NA detection, genetic disease diagnostics,
evolutionary biology, agriculture R&D and industry, and food safety
testing (Heyries et al., 2011; Jiang et al., 2014; Liao et al., 2005; Liao
et al., 2013; Maltezos et al., 2008).
In spite of the many advantages of microﬂuidic PCR, there are still
many challenges to overcome in developing an eﬃcient microﬂuidic
PCR device. The major drawbacks of microﬂuidic PCR are bubble for-
mation, non-speciﬁc adsorption of biological samples and integration of
microﬂuidic components, such as micro-pumps, valves and mixers on a
microﬂuidic PCR platform (Zhang and Xing, 2007; Zhang et al., 2006).
In particular, regarding bubble formation, air trapped in the reaction
chamber can expand at high temperatures and lead to sample eva-
poration, a temperature drop, and expulsion of the PCR solution out of
the reaction chamber (Karlsson et al., 2013; Nakayama et al., 2010;
Prakash et al., 2006). In particular, the evaporation of PCR reagent
during thermal cycles is signiﬁcant problem, when the temperature
approaches 95 °C at the denaturation step. The air bubble in the PCR
chamber can expand quickly, accompanied with increasing pressure,
then it can purge the PCR reagent out of the PCR chamber which can
accelerate the evaporation. This cascade related to the evaporation is
critical for loss of PCR reagents in concentration and volume of PCR
solution because of the small sample volume and large surface-to-
volume ratio of microﬂuidic device. Previous bubble removal ap-
proaches in microﬂuidic PCR utilized porous structures, membranes,
and mplanting of parylene, poly(vinyl alcohol), Teﬂon, and poly-
ethylene (PE), which also used for the same purpose in our study (Liu
et al., 2007; Shin et al., 2003; Xu et al., 2010). Therefore, these pro-
blems must be controlled carefully during thermal cycling to facilitate
NA ampliﬁcation in the most eﬀective manner. Thus, for potential and
practical applications, many critical aspects must be considered and
improved to produce an eﬃcient microﬂuidic PCR, including 1) a
micro-machining technology for use with substrate materials, fabrica-
tion, bonding and sealing, 2) design parameters, such as the archi-
tecture of PCR reaction chambers regarding the handling of sample
ﬂuids, including ﬂow-through/stationary PCR chamber formats, and 3)
analytical and signal processing methods for detection of amplicons and
the integration of these methods with other functional units, such as a
sample preparation, miniaturized thermal cycler, and detection module
to construct the POCT device (Almassian et al., 2013).
Here, we report the design, theoretical analysis, fabrication and
characterization of bubble-free microﬂuidic PCR devices for potential
applications in the POC molecular diagnostics. Theoretical modeling, in
addition to consideration of the design parameters of PCR chambers for
bubble-free PCR in a conﬁned microﬂuidic environment, was con-
ducted to ensure a bubble-free environment in a microﬂuidic PCR re-
action. Based on the theoretical analysis, we designed and fabricated
bubble-free microﬂuidic PCR devices with two diﬀerent types of poly-
meric materials, poly(dimethylsiloxane) (PDMS) and polyethylene (PE)
with two diﬀerent functionalities: 1) the high-gas solubility of PDMS for
stand-alone bubble-free sample loading, and 2) the liquid/gas barrier
property of PE for a bubble-free environment during the PCR reaction
Fig. 1. Schematic illustration of a bubble-free microﬂuidic PCR chip. (a) Comparison of convention-al benchtop and microﬂuidic PCR for rapid nucleic acid diag-
nostics, (b) Schematic illustration of a bubble-free microﬂuidic PCR device embedded in polyethylene (PE) barrier layer for reliable PCR reaction. This microﬂuidic
PCR chip consists of a PCR chamber (500 µm in diameter and 100 µm in height), and a polymer layer for bubble-free PCR. (c) Principle of a PE barrier on a
microﬂuidic PCR device. To prevent the loss of PCR ﬂuids by the liquid/gas diﬀusion through PDMS, the PE barrier layer was spin-coated. (d) Schematic illustration
of stand-alone s mpl loading in a hybrid PE-PDMS PCR c ip. Degas-driv n ﬂow is g nerated when the PCR chip is changed to an atmospheric pressure from a low
pressure environment. The circumferential degas channel can accelerate the suction ﬂow rate up to 6-fold. A-A indicates the cross-sectional view in the bottom side
ﬁgure, (e) Comparison of temperature proﬁles. i) and ii) represent the benchtop and Peltier-based thermal cycles, respectively.
S.H. Lee et al. %LRVHQVRUVDQG%LRHOHFWURQLFV²
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Figure 3: The design of the microfluidic PCR chip features a thin layer 
of PE sandwiched between two thicker layers of PDMS.1 The PE layer 
prevents PCR fluid (red arrows) from flowing out of the cell vertically, 
whereas gas flows out laterally through PDMS.
with air (Zhang et al., 2006). As a result, the loss of PCR solution only
exists as liquid bubbles in the circumferential degas chamber. The
phenomena presented here rely on the transport of liquid/gas through
the ring-shaped thin PDMS side wall from the PCR chamber into the
circumferential degas channel. Consequently, the functions of the cir-
cumferential degas channel are suitable for rapid degas-driven sample
loading by providing an additional vacuum source as well as the control
of bubble formation via the guided-bubble escapement.
3.4. Rapid PCR-based diagnosis for a NA biomarker
As mentioned above, our sample loading method relies on the high
gas solubility of PDMS due to its intrinsic porosity (Merkel et al., 2000).
A ﬂuidic actuation force within the microﬂuidic PCR device was gen-
erated by degassing in a low-pressure environment. We designed two
types of PCR chambers in the presence/absence of circumferential
degas channels, as shown in the SEM images of Fig. 4a. The PCR ﬂuid
was loaded which then moved along the ﬂow channel by degas-driven
ﬂow. Entire PCR chambers were completely ﬁlled with PCR ﬂuid. In the
case of the ring-shaped PCR chamber, a high ﬂow rate was generated
most of the time, however, the ﬂow was decreased for a short time at
the end of the sample loading process. No trapped air bubbles in the
microscopic observation remained in the PCR chambers. Fig. 4b depicts
the sample loading rate analyzed from time lapse images. The air from
the PCR chamber easily seeped out into the neighboring circumferential
channel during the suction process. After the sample loading, the
Fig. 4. Ampliﬁcation of cMET using bubble-free microﬂuidic PCR. (a) Stand-alone sample loading with and without a circumferential degas channel at same
degassing times. An image was taken every 10 s (b) Comparison of sample loading rates. (c) Calibration curve of the cMET gene at diﬀerent initial concentrations of
cDNA in the benchtop thermal cycler. (d) Agarose gel electrophoresis showing cMET gene ampliﬁcation. Lanes 1, 2 and 3 are a low molecular weight DNA ladder, an
amplicon for cMET from the benchtop PCR and rapid microﬂuidic PCR, respectively. The ﬂuorescence intensity at diﬀerent concentrations of TaqMan probe (e) and
polymerase (f). (g) Schematic illustration of rapid bubble-free microﬂuidic PCR setup. A Peltier-based thermal cycler system runs one thermal cycle in approximately
3.7 s and completes a 35-cycle PCR in 2 min 10 s (h) Temperature proﬁles of Peltier-based rapid thermal cyclers. These data were recorded with a thermocouple. (i)
The ﬂuorescence signals from rapid microﬂuidic PCR and benchtop PCR at a concentration of 3.75 × 103 copies/µl of cDNA. A channel inlet was sealed with PCR
tape on the top layer after the loading of 3 µl PCR ﬂuid by degas-driven ﬂow. The signal of ‘no template’ test was obtained from the microﬂuidic PCR test.
S.H. Lee et al. %LRVHQVRUVDQG%LRHOHFWURQLFV²

Figure 4: The role of the circumferential degas pump.1 It ensures uniform flow of the PCR fluid into the reaction chamber.
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plasmonic bacteria on the surface of a gold mirror, because we’re try-
ing to amplify as much as possible. We’re doing all kinds of different 
things to increase the vibrational peak of surface proteins on these 
pathogens. It’s not an easy job, but we want to figure out whether we 
can accumulate enough data to distinguish from pathogen to patho-
gen. But without the gold we cannot get any signal.
BSJ: You explained that you measure the plasmonic bacteria signal on a thin gold mirror dotted with nanopores. How 
do these nanopores contribute to trapping plasmonic bacteria?2 
LL: In our system, polycarbonate plastic is cased with a thin gold layer, which is dotted with nanopores. Around the edges 
of the nanopores, we see what are called “hot spots,” which are gen-
erated by more electron oscillation (Fig. 4). More electron oscillation 
means more radiation. It’s like an antenna—which is nothing more 
than a simple rod structure with oscillating electrons. What happens 
if you oscillate electrons in the surrounding area? An electromag-
netic field is generated, which we can detect. But we want to get as 
much information as we can out of that field. Many people have 
tried to make nanopillars or nanostructures to enhance this signal - 
something with a sharp tip. But here, instead of using a sharp tip, we 
use nanopores because we want to trap more of the pathogen. If we 
weren’t trying to filter out bacteria, we wouldn’t use nanopores —we 
would use a sharp tip structure. 
 
BSJ: How may rapid detection of waterborne pathogens en-abled by your optofluidic mechanism contribute to our 
understanding of the pathogenic genome? 
LL: We need to mass-produce these technologies to disseminate to the Third World. That was my dream. It’s a “chicken and 
egg” problem because many venture capitalists want to make money 
right away, and this kind of thing doesn’t make money right away. 
They value a winner’s market. Waterborne pathogen detection is not 
really a big market. That means we have to invest in technologies 
with a social responsibility. That’s why I started BIGHEART. After 
all, we are in Berkeley and we shouldn’t give up. Social responsibil-
ity is important, because these pathogens are connected with real 
health problems. You may think that the health problems in the 
Third World will not affect us, but actually, these pathogens circulate 
through the air, or traffic, or even the food that we import. We have 
to think about how to use our resources wisely to prevent and miti-
gate these global health problems.
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nanoparticles modiﬁed with speciﬁc antibodies or Raman
active dyes or magnetic nanoparticles for the enrichment
of bacteria, have also been demonstrated. However, the
previously proposed SERS-based detection methods are
generally limited to small sample volumes of a few
microliters. Considering that waterborne bacteria are
dispersed at very low concentrations, processing small
sample volume undermines the reliability of detection.
Therefore, besides high sensitivity and rapid detection
time, an ideal SERS-based method for detecting water-
borne bacteria should be capable of treating large sample
volumes.
Here, we report plasmonic bacteria on a nanoporous
mirror via hydrodynamic trapping, which allows enrich-
ment of bacteria from large sample volumes and strong
signal ampliﬁcations for the rapid identiﬁcation of bac-
teria. Our design is schematically illustrated in Fig. 1.
First, gold nanoparticles (GNPs) are spontaneously self-
assembled to form antenna arrays on the surface of bac-
teria (plasmonic bacteria). Then, plasmonic bacteria are
forced to be located on the nanopore of the membrane as
a result of hydrodynamic trapping (Fig. 1a). Hydro-
dynamic trapping enables the enrichment of bacteria on
the nanopore from large sample volumes. Once bacteria
are trapped on the pore, owing to the synergistic con-
tributions of (1) focused light by constructive interference
between incident light and its diffraction via the nano-
pore, (2) self-assembled nanoplasmonic antennas on the
surface of bacteria, and (3) plasmonic mirrors, a strong
near-ﬁeld enhancement between GNPs on plasmonic
bacteria, as well as between GNPs on plasmonic bacteria
with a gold thin mirror around the nanopore, (Fig. 1b) is
expected. Sensitive label-free optical detection of bacteria
from large sample volumes would therefore be possible
with this design.
Results
For the self-assembly of GNPs on the bacterial surface,
hydroxylamine hydrochloride (HAHC) is used to reduce
the strongly negative surface charge of citrate-capped
GNPs by replacing citrate ions with HAHC. Then,
HAHC-modiﬁed GNPs with a diameter of 20 nm are
mixed with Escherichia coli (E. coli). The representative
scanning electron microscope (SEM) image in Fig. 2a,
taken after mixing, shows that E. coli cells are densely
covered by GNPs. To further verify the self-assembly of
GNPs on the surface of E. coli, UV-vis spectra were
measured before and after the mixing. Figure 2b shows
the absorbance spectra of an E. coli solution, HAHC-
modiﬁed GNP solution, and mixed solution of E. coli and
HAHC-modiﬁed GNPs. Before mixing GNPs with E. coli,
the absorbance spectrum of the HAHC-modiﬁed GNP
solution exhibits a single surface plasmon resonance
(SPR) band at 522 nm. After mixing, this SPR band is
slightly redshifted (Δλ= 4 nm), and another broad SPR
band is observed in the near-infrared (NIR) region,
b Incident wave
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High RI
Diffracted wave
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interference
a
z
x
≡ Gold nanoparticle (GNP)
z
x
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Fig. 1 Plasmonic bacteria on a nanoporous mirror membrane a Schematic illustration of hydrodynamic trapping of plasmonic bacteria on
nanopores. Owing to the hydrodynamic force on the bacteria surface, GNP-assembled bacteria (plasmonic bacteria) are forced to move along the
ﬂow and are located on the nanopore. b Schematic illustration of the constructive interference between incident light and diffracted light at the
fringe of the nanopore (left). The constructive interference leads to strong near-ﬁeld enhancement between the GNPs on the plasmonic bacteria as
well as the GNPs and the gold mirror (right)
Whang et al. Light: Science & Applications (2018)7:68 Page 2 of 9
Figure 5: Lee’s optofluidic platform.2 
It aims to enhance surface signals 
from pathogenic bacteria using GNP 
coatings and constructive interference 
with nanopores.
